Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer

Clinical Cancer Research

Volumn 2, Issue 6, 1996, Pages 923-928

  Hui, Rina ^a   Cornish, Ann L ^a   McClelland, Richard A ^b   Robertson, John F R ^c   Blamey, Roger W ^c   Musgrove, Elizabeth A ^a   Nicholson, Robert I ^b   Sutherland, Robert L ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; ESTROGEN RECEPTOR; MESSENGER RNA;

ARTICLE; BREAST CANCER; CHROMOSOME 11Q; CONTROLLED STUDY; GENE LOCUS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION;

BREAST NEOPLASMS; CYCLIN D1; FEMALE; GENE AMPLIFICATION; HUMANS; RECEPTORS, ESTROGEN; RNA, MESSENGER;

EID: 0029888469     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. 1 cyclins. Cell, 73: 1059-1065, 1993.
2. Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., and Weinberg, R. A. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell, 82: 621-630, 1995.
3. Fantl, V., Stamp, G., Andrews, A., Rosewell, I., and Dickson, C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev., 9: 2364-2372, 1995.
4. Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., and Schmidt, E. V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (Lond.), 369: 669-671, 1994.
5. Musgrove, E. A., Hamilton, J. A., Lee, C. S., Sweeney, K. J., Watts, C. K., and Sutherland, R. L. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol. Cell. Biol., 13: 3577-3587, 1993.
6. Watts, C. K. W., Brady, A., Sarcevic, B., deFazio, A., Musgrove, E. A., and Sutherland, R. L. Antiestrogen inhibition of cell cycle progression in breast cancer cells is associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. Mol. Endocrinol., 9: 1804-1813, 1995
7. Musgrove, E A., Lee, C. S., Buckley, M F., and Sutherland, R. L. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. Natl. Acad. Sci. USA, 91: 8022-8026, 1994.
8. Adnane, J., Gaudray, P., Simon, M. P., Simony-Lafontaine, J., Jeanteur, P., and Theillet, C. Proto-oncogene amplification and human breast tumor phenotype. Oncogene, 4: 1389-1395, 1989.
9. Fantl, V., Richards, M. A., Smith, R., Lammie, G. A., Johnstone, G., Allen, D., Gregory, W., Peters, G., Dickson, C., and Barnes, D. M. Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. Eur. J. Cancer, 26: 423-429, 1990.
10. Borg, A., Sigurdsson, H., Clark, G. M., Ferno, M., Fuqua, S. A , Olsson, H., Killander, D., and McGurie, W. L. Association of INT2/ HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br. J. Cancer. 63: 136-142, 1991.
11. Berns, E. M., Klijn, J. G., van Staveren, I. L., Portengen, H., Noordegraaf, E., and Foekens, J. A. Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors. Eur. J. Cancer, 28:697-700, 1992.
12. Seshadri, R., Lee, C. S. L., Hui, R., McCaul, K., Horsfall, D. J., and Sutherland, R. L. Cyclin D1 amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis. Clin. Cancer Res., in press, 1996.
13. Machotka, S. V., Garrett, C. T., Schwartz, A. M., and Callahan, R. Amplification of the proto-oncogenes int-2, c-erb B-2, and c-myc in human breast cancer. Clin. Chim. Acta, 184: 207-217, 1989.
14. Schuuring, E., Verhoeven, E., van Tinteren, H., Peterse, J. L., Nunnink, B., Thunnissen, F. B., Devilee, P., Cornelisse, C. J., van de Vijver, M. J., Mooi, W. J., and Michalides, R. J. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res., 52:5229-5234, 1992.
15. Gaffey, M. J., Frierson, H., Jr., and Williams, M. E. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations. Mod. Pathol., 6: 654-659, 1993.
16. Henry, J. A., Hennessy, C., Levett, D. L., Lennard, T. W., Westley, B. R., and May, F. E. int-2 amplification in breast cancer: association with decreased survival and relationship to amplification of c-erbB-2 and c-myc. Int. J. Cancer, 53: 774-780, 1993.
17. Berns, P. M., Klijn, J. G., Staveren, I. L., Smid, M., Look, M. P., and Foekens, J. A. Distinct gene alterations as related with prognosis in human primary breast cancer. Breast Cancer Res. Treat., 32 (Suppl.): 92, 1994.
18. Buckley, M. F., Sweeney, K. J., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., deFazio, A., Watts, C. K., Musgrove, E. A., and Sutherland, R. L. Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8: 2127-2133, 1993.
19. Fantl, V., Smith, R., Brookes, S., Dickson, C., and Peters, G. Chromosome 11q13 abnormalities in human breast cancer. Cancer Surv., 18: 77-94, 1993.
20. Gillett, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D , and Peters, G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54: 1812-1817, 1994.
21. Bartkova, J., Lukas, J., Muller, H., Lutzhoft, D., Strauss, M., and Bartek, J. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer, 57: 353-361, 1994.
22. Bartkova, J., Lukas, J., Strauss, M., and Bartek, J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene, 10: 775-778, 1995.
23. McIntosh, G. G., Anderson, J. J., Milton, I., Steward, M., Parr, A. H., Thomas, M. D , Henry, J. A., Angus, B., Lennard, T. W., and Horne, C. H. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene, 11: 885-891, 1995.
24. Holmes, F. A., Fritsche, H. A., Loewy, J. W., Geitner, A. M., Sutton, R. C., Buzdar, A. U., and Hortobagyi, G. N. Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay. J. Clin. Oncol., 8: 1025-1035, 1990.
25. Nagai, M. A., Marques, L. A., Yamamoto, L., Fujiyama, C. T., and Brentani, M. M. Estrogen and progesterone receptor mRNA levels in primary breast cancer: association with patient survival and other clinical and tumor features. Int. J. Cancer, 59: 351-356, 1994.
26. Daffada, A. A., Johnston, S. R., Nicholls, J., and Dowsett, M. Detection of wild type and exon 5-deleted splice variant oestrogen receptor (ER) mRNA in ER-positive and -negative breast cancer cell lines by reverse transcription/polymerase chain reaction. J. Mol. Endocrinol., 13: 265-273, 1994.
27. Romain, S., Formento, J. L., Guirou, O., Francoual, M., Milano, G., and Martin, P. M. Determination of oestrogen receptors by enzyme immunoassay. Eur. J. Cancer. 6: 740-746, 1994.
28. Nicholson, R. I., Bouzubar, N., Walker, K. J., McClelland, R., Dixon, A. R., Robertson, J. F., Ellis, I O , and Blamey, R. W. Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation. Eur. J. Cancer, 27: 908-913, 1991.
29. Walker, K. J., McClelland, R. A., Candlish, W., Blamey, R. W., and Nicholson, R. I. Heterogeneity of oestrogen receptor expression in normal and malignant breast tissue. Eur. J. Cancer, 28: 34-37, 1992.
30. Bezwoda, W. R., Esser, J. D., Dansey, R., Kessel, I., and Lange, M. The value of estrogen and progesterone receptor determinations in advanced breast cancer. Cancer (Phila.), 68: 867-872, 1991.
31. Chapman, J. A., Mobbs, B. G., Hanna, W. M., Sawka, C. A., Pritchard, K. I., Lickley, H. L., Trudeau, M. E., Ryan, E. D., Ooi, T. C., Sutherland, D. J., Tustanoff, E. R., and McCready, D. R. The standardization of estrogen receptors. J. Steroid Biochem. Mol. Biol., 45: 367-373, 1993.
32. Mobbs, B. G., Chapman, J. A., Sutherland, D. J., Ryan, E., Tustanoff, E. R., Ooi, T. C., and Murthy, P. V. Evidence for bimodal distribution of breast carcinoma ER and PgR values quantitated by enzyme immunoassay. Eur. J. Cancer, 29A: 1293-1297, 1993.
33. Thorpe, S. M., Christensen, I. J., Rasmussen, B. B., and Rose, C. Short recurrence-free survival associated with high oestrogen receptor levels in the natural history of postmenopausal primary breast cancer. Eur. J. Cancer, 29A: 971-977, 1993.
34. Tang, R. P., Kacinski, B., Validire, P., Beuvon, F., Sastre, X., Benoit, P., dela Rochefordiere, A., Mosseri, V., Pouillart, P., and Scholl, S. Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells? J. Cell. Biochem., 44: 189-198, 1990.
35. Berns, E., Foekens, J., van Staveren, I., van Putten, W., de Koning, H , Portengen, H., and Klijn, J. Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment. Gene (Amst.), 159: 11-18, 1995.
36. Tsuda, H., Hirohashi, S., Shimosato, Y., Hirota, T., Tsugane, S., Yamamoto, H., Miyajima, N., Toyoshima, K., Yamamoto, T., Yokota, J., Yoshida, T., Sakamoto, H., Terada, M., and Sugimura, T. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. Cancer Res., 49: 3104-3108, 1989.